No to EMA’s provision of confidential scientific advice to drug companies (November 2017)

Paris, 28 November 2017

Prescrire, along with around 20 civil society organisations, has signed a joint declaration drawing attention to potential problems posed by the provision of confidential scientific advice by the European Medicines Agency to pharmaceutical companies, especially a decline in regulatory standards, a risk of institutional capture, and a total lack of transparency surrounding the activity of European regulatory authorities.

> Click here to download the joint declaration (413 Ko)